Junli Zhang

Junli Zhang

Auto-generated profile, based on publicly available information

Junli Zhang

Jiangsu Provincial Hospital of Traditional Chinese Medicine, Nanjing, People’s Republic of China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2024 in Journal of Inflammation Research
Verified
Journal Article
Open access
PDF file
NLNa Li
Na Li
LHLiyuan Hao
Liyuan Hao
SLShenghao Li
Shenghao Li
JDJiali Deng
Jiali Deng
FYFei Yu
Fei Yu
XHXiaoyu Hu
Xiaoyu Hu
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a progressive liver disorder with a rising prevalence. It begins with lipid accumulation in hepatocytes and gradually progresses to Metabolic-associated steatohepatitis (MASH), fibrosis, cirrhosis, and potentially hepatocellular carcinoma (HCC). The pathophysiology of MASLD is complex and involves multiple factors, with oxidative stress playing a crucial role. Oxidative stress drives the progression of MASLD by causing cellular damage, inflammatory responses, and fibrosis, making it a key pathogenic mechanism. The Nuclear Factor Erythroid 2-Related Factor 2 / Heme Oxygenase-1 (Nrf2/HO-1) signaling axis provides robust multi-organ protection against a spectrum of endogenous and exogenous insults, particularly oxidative stress. It plays a pivotal role in mediating antioxidant, anti-inflammatory, and anti-apoptotic responses. Many studies indicate that activating the Nrf2/HO-1 signaling pathway can significantly mitigate the progression of MASLD. This article examines the role of the Nrf2/HO-1 signaling pathway in MASLD and highlights natural compounds that protect against MASLD by targeting Nrf2/HO-1 activation. The findings indicate that the Nrf2/HO-1 signaling pathway holds great promise as a therapeutic target for MASLD.

5 January 2025 in Phytomedicine
Verified
Journal Article
Closed access
JZJunli Zhang
Junli Zhang
LHLiyuan Hao
Liyuan Hao
SLShenghao Li
Shenghao Li
YHYing He
Ying He
YZYang Zhang
Yang Zhang
XHXiaoyu Hu
Xiaoyu Hu

11 January 2024 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
SBSixue Bi
Sixue Bi
YJYongshuai Jing
Yongshuai Jing
XCXuehui Cui
Xuehui Cui
YGYitong Gong
Yitong Gong
JZJunli Zhang
Junli Zhang
DLDefang Li
Defang Li

1 January 2024 in Journal of Immunology Research
Verified
Journal Article
Open access
PDF file
JZJunli Zhang
Junli Zhang
NLNa Li
Na Li
XHXiaoyu Hu
Xiaoyu Hu
Acute liver failure (ALF) is a fulminant clinical syndrome that usually leads to multiple organ failure and high mortality. Macrophages play a crucial role in the initiation, development, and recovery of ALF. Targeting macrophages through immunotherapy holds significant promise as a therapeutic strategy. These cells exhibit remarkable plasticity, enabling them to differentiate into various subtypes based on changes in their surrounding microenvironment. M1‐type macrophages are associated with a pro‐inflammatory phenotype and primarily rely predominantly on glycolysis. In contrast, M2‐type macrophages, which are characterized by anti‐inflammatory phenotype, predominantly obtain their energy from oxidative phosphorylation (OXPHOS) and fatty acid oxidation (FAO). Shifting macrophage metabolism from glycolysis to OXPHOS inhibits M1 macrophage activation and promotes M2 macrophage activation, thereby exerting anti‐inflammatory and reparative effects. This study elucidates the relationship between macrophage activation and glucose metabolism reprograming from an immunometabolism perspective. A comprehensive literature review revealed that several signaling pathways may regulate macrophage polarization through energy metabolism, including phosphatidyl‐inositol 3‐kinase/protein kinase B (PI3K/AKT), mammalian target of rapamycin (mTOR)/hypoxia‐inducible factor 1α (HIF‐1α), nuclear factor‐κB (NF‐κB), and AMP‐activated protein kinase (AMPK), which exhibit crosstalk with one another. Additionally, we systematically reviewed several traditional Chinese medicine (TCM) monomers that can modulate glucose metabolism reprograming and influence the polarization states of M1 and M2 macrophages. This review aimed to provide valuable insights that could contribute to the development of new therapies or drugs for ALF.

1 December 2024 in Drug Design, Development and Therapy
Verified
Journal Article
Open access
PDF file
NLNa Li
Na Li
JZJunli Zhang
Junli Zhang
FYFei Yu
Fei Yu
FYFanghang Ye
Fanghang Ye
WTWanying Tan
Wanying Tan
XHXiaoyu Hu
Xiaoyu Hu
In recent years, the incidence of fungal infections has been rising annually, especially among immunocompromised populations, posing a significant challenge to public health. Although antifungal medications provide some relief, the escalating problem of resistance sharply curtails their effectiveness, presenting an urgent clinical dilemma that demands immediate attention. Research has shown that fungal resistance is closely related to quorum sensing (QS), and QS inhibitors (QSIs) are considered an effective solution to this issue. Garlic, as a natural QSI, has demonstrated significant effects in inhibiting fungal growth, preventing biofilm formation, enhancing immunity, and combating resistance. This study explores the potential of garlic in mitigating fungal drug resistance and identifies its key role in inhibiting the QS mechanism, these findings offer a new perspective for the treatment of fungal infections, especially in addressing the increasingly severe problem of resistance. However, the clinical application of garlic still faces several challenges, such as ensuring the standardization of active ingredient extraction, as well as issues of safety and stability. Future research should focus on the QS mechanism and promote interdisciplinary collaboration to develop more natural, effective, and safe QSI drugs like garlic, while actively conducting clinical trials to validate their efficacy and safety. Additionally, incorporating advanced technologies such as nanotechnology to enhance drug stability and targeting, provide a more comprehensive strategy for the treatment of fungal infections. Overall, Our study provides scientific evidence supporting the potential of garlic as a novel antifungal treatment and lays the groundwork for the development of future natural QSIs for therapeutic use. It offers new insights, particularly for the treatment of immunocompromised populations and drug-resistant fungal strains.

1 October 2024 in Drug Design, Development and Therapy
Verified
Journal Article
Open access
PDF file
SLShenghao Li
Shenghao Li
LHLiyuan Hao
Liyuan Hao
JDJiali Deng
Jiali Deng
JZJunli Zhang
Junli Zhang
FYFei Yu
Fei Yu
XHXiaoyu Hu
Xiaoyu Hu
Hepatitis B virus (HBV) is a globally prevalent human DNA virus responsible for over 250 million cases of chronic liver infections, leading to conditions such as liver inflammation, cirrhosis and hepatocellular carcinoma (HCC). Sodium taurocholate co-transporting polypeptide (NTCP) is a transmembrane protein highly expressed in human hepatocytes and functions as a bile acid (BA) transporter. NTCP has been identified as the receptor that HBV and its satellite virus, hepatitis delta virus (HDV), use to enter hepatocytes. HBV entry into hepatocytes is tightly regulated by various signaling pathways, and NTCP plays an important role as the initial stage of HBV infection. NTCP acts as an initiation signal, causing metabolic changes in hepatocytes and facilitating the entry of HBV into hepatocytes. Thus, a comprehensive understanding of NTCP’s role is crucial. In this review, we will examine the regulatory mechanisms governing HBV pre-S1 binding to liver membrane NTCP, the role of NTCP in HBV internalization, and the transcriptional and translational regulation of NTCP expression. Additionally, we will discuss clinical drugs targeting NTCP, including combination therapies involving NTCP inhibitors, and consider the safety of NTCP as a therapeutic target.